Insiders · Profile

Sah Dinah Ph.D.

Chief Scientific Officer at Voyager Therapeutics. Filing since 27 Feb 2018. CIK 0001711043

Company

Date

Role

Action

Amount

Of holding

27 Feb 2018

Chief Scientific Officer

Sold, plan not stated

15,623

$468.69K

10.1%

1 decision on file.